The Journal of Hypo & Hyperglycemia (JHHG) promotes rigorous research that makes a significant contribution in advancing knowledge for diabetes medication. JHHG includes all major themes pertaining to diabetes and related side effects.
Journal of Hypo & Hyperglycemia is a subscription based journal that provides a range of options to purchase our articles and also permits unlimited Internet Access to complete Journal content. It accepts research, review papers, online letters to the editors & brief comments on previously published articles or other relevant findings in SciTechnol. Articles submitted by authors are evaluated by a group of peer review experts in the field and ensures that the published articles are of high quality, reflect solid scholarship in their fields, and that the information they contain is accurate and reliable.
Longitudinal Studies of Diabetes in Environmental Epidemiology: Is Incident Diabetes the Right Outcome?
While numerous cross-sectional studies have shown associations between environmental pollutants and diabetes, the results of longitudinal studies have been mixed. The question remains, why do some longitudinal studies of incident diabetes and environmental pollutants have negative results?
The Effect of Colestimide on Visceral Fat Mass and Cytokine Levels in Patients with Metabolic Syndrome
Bile acid–binding resins (BABRs) improve hyperglycemia in patients with type 2 diabetes, and the BABR colesevelam has been approved by the U.S. Food and Drug Administration for use as an antihyperglycemic agent. Colestimide (colestilan) is a new type of anion resin that increases the number of hepatic low-density lipoprotein receptors and decreases serum cholesterol levels by promoting the excretion of bile acids and inhibiting the absorption of cholesterol in the intestine; with these changes, the serum level of low-density lipoprotein cholesterol decreases.
Diabetes mellitus, as a common metabolic disease, affects millions people’s health worldwide and its incidence is continuing to increase. It is important to find effective measures of prevention and/or intervention for the disease to reduce its impact on the risk for cardiovascular disease – the leading cause of mortality among patients with diabetes mellitus. Apart from its well-known “classic” effect in bone metabolism, vitamin D has received widespread attention for its potential role in the prevention of diabetes mellitus, in particular type 2 diabetes mellitus.
Myocardial Flow Reserve Partially Recovered after Additional Intensive Anti-Hyperglycemic Therapy in Patients with Type 2 Diabetes
Impaired myocardial perfusion, such as coronary microangiopathy, is one of the important pathophysiological characteristics of diabetes and a clinically important unresolved clinical question. The importance of glycemic control in the development of atherosclerosis in patients with diabetes has been suggested. We previously reported that myocardial flow reserve (MFR) was related to glycemic control rather than to the mode of therapy in patients with type 2 diabetes (T2DM).
